Hematological neoplasm
Basic details
Preferred term: Hematological neoplasm
Alt. terms: Blood tumor | hematological malignancy
HPO term: Hematological neoplasm
HPO code: HP:0004377
GenIA ID: 229
Last updated on: 2021-12-10 17:55:48
Cross ref. with other ontologies
NCIT: -
MESH: D019337
EFO: -
OAE: -
SNOMEDCT: -
ICD10: -
Description
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
Hierarchical classification
TERM
Hematological neoplasm
Reported patients added to GenIA DB
| SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
|---|---|---|---|---|---|---|---|
| 101121 | M | 210784 | 47 | German | Lymphoma | PMID:34975878 [Fam.F072:P072] | |
| 101160 | F | 211433 | - | Hematological neoplasm | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F101:P101] | |
| 101269 | M | 212146 | 5 | Saudi | Lymphoproliferative disorder | PMID:22721650 [Fam.VI:5:I.1] | |
| 101295 | M | 212146 | 5 | Saudi | Lymphoproliferative disorder | Immunodeficiency, common variable, 8 | PMID:22721650 [VI:5(VI.5)]; PMID:26707784 [P6] |
| 101387 | M | 211537 | - | German | Hematological neoplasm | PMID:34975878 [Fam.F136:P136] | |
| 101392 | M | 212166 | 2 | Palestinian | Lymphoproliferative disorder | Immunodeficiency, common variable, 8 | PMID:25931386 [Fam.2:II.3(P4)]; PMID:26707784 [P23] |
| 101462 | M | 210006 | - | Hematological neoplasm | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F154:P154] | |
| 101544 | F | 211170 | - | Hematological neoplasm | PMID:34975878 [Fam.F180:P180] | ||
| 101549 | F | 212463 | - | British | Lymphoma | Activated p110-delta syndrome 1 | PMID:24136356 [Fam.E:I.1(P13)] |
| 101720 | F | 210022 | - | Iranian | Lymphoproliferative disorder | Immunodeficiency, common variable, 8 | PMID:26768763 [Fam.134:II.2(P5)]; PMID:25539626 [P1(II.1)]; PMID:26707784 [P12] |
| 101808 | F | 211441 | - | Hematological neoplasm | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F265:P265] | |
| 101951 | M | 212062 | - | Hematological neoplasm | PMID:34975878 [Fam.F375:P375] | ||
| 102225 | M | 214920 | - | Romanian | Lymphoma | Immunodeficiency 40 | PMID:35486341 [P063] |
| 102509 | M | 214948 |
3 | Irish Traveller | Lymphoproliferative disorder | Immunodeficiency 54 | PMID:16532402 [Fam.A:IV.12(P3)]; PMID:22354167 [Fam.A:IV.12(P1.3)] |
| 102803 | F | 214991 |
16 | North American | Lymphoma | Immunodeficiency 8 | PMID:25073507 [P1(II.2)] |
| 103485 | F | 215137 |
- | French | Myelodysplasia | Immunodeficiency 55 | PMID:28414293 [Fam.D:II.1(P5)] |
| 103788 | M | 215242 |
- | South Korean | Lymphoma | Hyper-IgE recurrent infection syndrome 1 | PMID:19348930 [Patient(II.1)] |
| 104001 | F | 215322 |
2 | North American | Lymphoproliferative disorder | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P5]; PMID:32392079 [P3]; PMID:30092289 [P15]; PMID:35677041 [Pt3]; PMID:33651637 [Patient 1] |
| 104639 | F | 215562 | 11 | Iraqi | Lymphoproliferative disorder | Immunodeficiency 91 and hyperinflammation | PMID:33872655 [Fam.A:II.2(P1.2)] |
| 105248 | F | 215676 | 12 | Turkish | Lymphoproliferative disorder | Immunodeficiency, common variable, 8 | PMID:28956255 [P2(II.1)] |
| 105363 | F | 215722 |
- | Afro-American | Lymphoproliferative disorder | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.X:II.1(X.II.1 (59))]; PMID:28366794 [Fam.A:II.1(P1)]; PMID:34111452 [X.II.1 (59)] |
| 105385 | M | 215736 | 3 | Lymphoproliferative disorder | Immunodeficiency, common variable, 8 | PMID:29183106 [P7] | |
| 105400 | M | 215751 | - | Turkish | Lymphoproliferative disorder | Immunodeficiency, common variable, 8 | PMID:32219082 [Patient 1] |
| 105424 | M | 215766 |
- | Admixed | Leukemia | Adenosine deaminase 2 deficiency | PMID:26867732 [Fam.F:II.1(P8)]; PMID:25457153 [Fam.1:II.2(P1)]; PMID:25075846 [Fam.1:II.2(older-sib)] |
| 105470 | M | 215774 | - | Iranian | Lymphoproliferative disorder | NFKB1 insufficiency | PMID:150198 [Fam.BP:309]; PMID:31117086 [P35] |
| 105568 | M | 215809 | 6 | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:24698326 [Fam.A:II.1(P2)] | |
| 105573 | U | 215812 | - | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:24698326 [P4] | |
| 105574 | U | 215813 | - | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:24698326 [P5] | |
| 105576 | U | 215815 | - | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:24698326 [P8] | |
| 105580 | F | 215756 | 13 | Druze | Leukemia | PMID:33013830 [Fam.Patient:II.5(sister)] | |
| 105587 | F | 215820 | 3 | Caucasian | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.1:II.1(F1P1)] |
| 105591 | F | 215821 | 1 | Caucasian | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.2:II.1(F2P2)] |
| 105609 | M | 215821 | - | Caucasian | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:24610295 [Fam.2:III.1(F2P3)] |
| 105623 | M | 215822 | 6 | Caucasian | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:II.6(P2)] |
| 105635 | F | 215829 | - | Caucasian | Lymphoproliferative disorder | Activated p110-delta syndrome 1 | PMID:26371693 [1] |
| 105651 | F | 210401 |
- | German | Leukemia | PMID:150198 [Fam.BW:I.2(349)] | |
| 105968 | M | 215916 |
7 | Japanese | Lymphoproliferative disorder | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.U:II.1(U.II.1 (50))]; PMID:30048690 [Fam.1:II.1(P1.2)]; PMID:34111452 [U.II.1 (50)]; PMID:35087518 [Fam.13:II.1(13.2)]; PMID:28960754 [CTLA4-Case1] |
| 105977 | F | 215918 |
- | Japanese | Lymphoproliferative disorder | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.W:II.2(W.II.2 (56))]; PMID:30048690 [Fam.2:II.2(P2.2)]; PMID:34111452 [W.II.2 (56)]; PMID:35087518 [Fam.15:II.2(15.3)] |
| 105981 | M | 215919 |
- | Caucasian | Lymphoproliferative disorder | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.Y:II.1(Y.II.1 (61))]; PMID:34111452 [Y.II.1 (61)] |
| 106321 | M | 215688 |
- | European | Lymphoma | PMID:150198 [Fam.AY:I.1(261)]; PMID:36105815 [Fam.I281M:I.1(father)] | |
| 106350 | M | 215996 | 75 | Multiple myeloma | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [CM.I.2] | |
| 106401 | F | 216006 |
19 | German | Lymphoproliferative disorder | PMID:36273440 [Fam.III.3:III.1] | |
| 106816 | F | 216162 | - | Hematopoyetic system abnormality | Immunodeficiency, common variable, 8 | PMID:39184709 [Fam.1:II.1(Patient)] | |
| 107226 | M | 216382 | - | North American | Lymphoproliferative disorder | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:35677041 [Pt6]; PMID:33651637 [Patient 2]; PMID:28349047 [Case] |
| 107355 | M | 216441 | 3 | Lymphoma | Immunodeficiency, common variable, 8 | PMID:33864888 [S014] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).